ATE359291T1 - Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna - Google Patents

Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna

Info

Publication number
ATE359291T1
ATE359291T1 AT99908097T AT99908097T ATE359291T1 AT E359291 T1 ATE359291 T1 AT E359291T1 AT 99908097 T AT99908097 T AT 99908097T AT 99908097 T AT99908097 T AT 99908097T AT E359291 T1 ATE359291 T1 AT E359291T1
Authority
AT
Austria
Prior art keywords
breast cancer
bcrp
dna coding
resistance protein
cancer resistance
Prior art date
Application number
AT99908097T
Other languages
English (en)
Inventor
Douglas D Ross
L Austin Doyle
Lynne Abruzzo
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22115664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE359291(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE359291T1 publication Critical patent/ATE359291T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99908097T 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna ATE359291T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7376398P 1998-02-05 1998-02-05

Publications (1)

Publication Number Publication Date
ATE359291T1 true ATE359291T1 (de) 2007-05-15

Family

ID=22115664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908097T ATE359291T1 (de) 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna

Country Status (10)

Country Link
US (4) US6313277B1 (de)
EP (1) EP1054894B2 (de)
JP (1) JP4187412B2 (de)
AT (1) ATE359291T1 (de)
AU (1) AU755567B2 (de)
CA (1) CA2319715C (de)
DE (1) DE69935782T3 (de)
ES (1) ES2284243T5 (de)
IL (4) IL137466A0 (de)
WO (1) WO1999040110A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE359291T1 (de) * 1998-02-05 2007-05-15 Univ Maryland Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
US7622557B2 (en) * 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
AU4214799A (en) 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
WO2000036101A2 (en) * 1998-11-30 2000-06-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services An atp-binding cassette protein responsible for cytotoxin resistance
US7138493B1 (en) * 1998-11-30 2006-11-21 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding cassette protein responsible for cytotoxin resistance
DE60030283T2 (de) * 1999-05-17 2007-09-20 Cancer Research Ventures Ltd. Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
EP1323735A4 (de) * 2000-10-03 2005-02-09 Banyu Pharma Co Ltd Gene mit bezug zu arzneimitteltoleranz und anwendung derselben
HU0100947D0 (en) * 2001-03-02 2001-05-28 Solvo Kft Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers
WO2003035685A1 (en) * 2001-10-24 2003-05-01 Solvo Biotechnology Inc. Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
US20060135445A1 (en) * 2003-02-04 2006-06-22 Kabushiki Kaisha Yakult Honsha Breast cancer-resistant protein inhibitor
JP2006069910A (ja) * 2004-08-31 2006-03-16 Yoshiichi Sugimoto 抗癌剤耐性克服剤
EP1672365A1 (de) * 2004-12-16 2006-06-21 Het Nederlands Kanker Instituut Mittel und Verfahren zur Bestimmung und Beeinflussung des zellulären Transports
US7465788B2 (en) * 2005-01-18 2008-12-16 University Of Maryland Breast cancer resistance protein (BCRP) and antibodies thereto
EP4056686A1 (de) 2012-09-11 2022-09-14 Corning Incorporated Verbrauchbare kryokonservierte zellen mit vorübergehender überexpression von gen(en), die für wirkstofftransporterprotein(e) und/oder wirkstoffmetabolisierende enzym(e) codieren
KR101561965B1 (ko) 2013-11-27 2015-10-20 한국과학기술연구원 디스코이딘 도메인 수용체 2 활성을 조절하는 물질의 동정 방법
EP3966340A4 (de) * 2019-05-08 2024-01-03 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) Terpen-synthasen und transporter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
AU6186398A (en) * 1997-02-24 1998-09-09 Tm Technologies, Inc. Process for selecting anti-sense oligonucleotides
WO1998055614A2 (en) * 1997-06-04 1998-12-10 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
ATE359291T1 (de) * 1998-02-05 2007-05-15 Univ Maryland Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
EP1105474A2 (de) * 1998-05-14 2001-06-13 Chiron Corporation Menschliche gene und genexpressionsprodukte v
EP1115865A2 (de) * 1998-09-25 2001-07-18 Bayer Ag Atp bindende kassettengene und proteine zur diagnose und behandlung von fettstörungen und entzündlichen krankheiten
WO2000036101A2 (en) * 1998-11-30 2000-06-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services An atp-binding cassette protein responsible for cytotoxin resistance
EP1323735A4 (de) 2000-10-03 2005-02-09 Banyu Pharma Co Ltd Gene mit bezug zu arzneimitteltoleranz und anwendung derselben
US20060057579A1 (en) 2002-06-17 2006-03-16 Banyu Pharmaceutical Co., Ltd., Method for predicting a drug transport capability by abcg2 polymorphisms

Also Published As

Publication number Publication date
AU755567B2 (en) 2002-12-12
IL137466A0 (en) 2001-07-24
IL177612A (en) 2011-04-28
JP2002502592A (ja) 2002-01-29
US7655755B2 (en) 2010-02-02
CA2319715A1 (en) 1999-08-12
EP1054894A4 (de) 2002-03-13
DE69935782T3 (de) 2017-01-05
AU2761099A (en) 1999-08-23
IL137466A (en) 2011-04-28
ES2284243T3 (es) 2007-11-01
EP1054894B2 (de) 2016-11-09
US7741445B2 (en) 2010-06-22
US7541437B2 (en) 2009-06-02
WO1999040110A1 (en) 1999-08-12
ES2284243T5 (es) 2017-08-22
CA2319715C (en) 2012-08-07
DE69935782D1 (de) 2007-05-24
IL191982A (en) 2011-09-27
IL191982A0 (en) 2008-12-29
DE69935782T2 (de) 2007-08-16
US20030036645A1 (en) 2003-02-20
US6313277B1 (en) 2001-11-06
US20050272684A1 (en) 2005-12-08
US20090104199A1 (en) 2009-04-23
EP1054894A1 (de) 2000-11-29
EP1054894B1 (de) 2007-04-11
JP4187412B2 (ja) 2008-11-26

Similar Documents

Publication Publication Date Title
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
EP1442295A4 (de) Diagnostische tests auf periostinbasis
EA199700447A1 (ru) Последовательность днк и кодируемый ею специфический для молочной железы белок карциномы молочной железы
CY1112101T1 (el) Νευροτροφικοι παραγοντες
DE69939982D1 (de) B7l-1 moleküle
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
ATE438719T1 (de) Spezifischer marker für prostatakrebs
ATE249209T1 (de) Arzneistoffträgerpartikel für die gewebespezifische arzneistoffapplikation
ATE484587T1 (de) Ldcam genannte moleküle
EE03693B1 (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
SG161738A1 (en) B-amyloid peptide-binding proteins and polynucleotides encoding the same
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
IL151448A0 (en) Proteins
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
SG165168A1 (en) New adenoviruses, nucleic acids coding therefor and their use
PE20399A1 (es) Muteina ob
ATE368733T1 (de) Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
ATE408687T1 (de) Semaphorin polypeptide
BR0315222A (pt) Promotor de il-18bp, sua preparação e uso
WO2001055209A3 (en) Novel human septin and uses thereof
DK0858465T3 (da) Protein med antitumorvirkning.
DE69739223D1 (de) Oden und anwendungen
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
EP1437364A3 (de) Androgen Rezeptor bindendes Polypeptid und dessen potentielle Verwendung zur Behandlung von Brustkrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties